Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins
Max Andrew Thorwald, José A. Godoy-Lugo, Naomi Santa Maria, Ararat Chakhoyan, Peggy A. O’Day, Russell Jacobs, Berislav V. Zloković, Caleb E. Finch
The paper shows oral DFO reduces brain iron and iron-related proteins in mice, suggesting potential therapeutic benefits for early-stage Alzheimer's.
Journal of Alzheimer s Disease · Feb 1, 2025Peer-reviewedNeuroscience